Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone vs Aripiprazole on Oxidative Stress in ASD
NCT05868720Unknown
- Sponsor
- AIIMS New Delhi
- Start
- Jul 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
01
Overview
Randomised trial of risperidone and aripiprazole in Autism Spectrum Disorder (ASD), sponsored by AIIMS New Delhi. Primary endpoint: Serum Glutathione at 6 weeks. Status: unknown.
02
Drugs
risperidonearipiprazole
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT05868720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05868720.